Aims: To investigate the relation between the numbers of interphase silver stained nucleolar organiser regions (AgNORs) and immunolabelling with the monoclonal antibody PCIO, which demonstrates proliferating nuclei by reacting with proliferating cell nuclear antigen (PCNA). Methods: The established sequential technique for the demonstration of interphase AgNORs and of antigens in paraffin wax sections was applied to a small series of non-Hodgkin's lymphomas (NHL) of both low and high grade type, together with specimens of palatine tonsil. The numbers of PCNA positive cells were counted in all specimens; in the tonsils the cells were counted in both follicle centres and in the interfollicular areas. The numbers of AgNORs in both PCNA positive and PCNA negative nuclei were then counted. Results: Lower numbers of PCNA positive cells were found in the low grade than the high grade NHL (18-28.4% and 34-2-513%, respectively). This was reflected in the two areas of the palatine tonsils, the counts being higher in the follicle centre nuclei than in those in the interfollicular compartments. In general, the numbers of AgNORs were higher in the PCNA positive nuclei than in those lacking the antigen; however, a consistent finding was that relatively high AgNOR scores were observed in PCNA negative nuclei, especially in the high grade lymphomas. In the tonsils, however, the AgNOR counts were much lower in the nuclei lacking PCNA than in those containing it. Conclusions: The results obtained in the lymphomas were rather unexpected as, in general, previous studies have shown a close direct or indirect relation between AgNOR scores and proliferating cell counts. An explanation for these findings may be that the argyrophil proteins associated with proliferating cells remain in the nucleus in detectable form longer than the PCNA antigen, at least in neoplastic tissue. (i Clin Pathol 1993;46:28-31) The scoring of interphase NOR numbers using the argyrophil (AgNOR) technique' has been shown to be of use in assessing the degree of malignancy in neoplasms.`-4 In the case of non-Hodgkin's lymphomas (NHL), AgNOR numbers can help to distinguish between high and low grade lymphomas"6 with greater scores in the high grade than in the low grade types. However, the reason for the increased count in the high grade lymphomas was not originally fully understood. In view of the constant chromosomal positions of NORs, it might be expected to reflect cell ploidy, but there is now a great volume of evidence showing that interphase AgNOR scores represent the level of cell proliferation.
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NORs are ribosomal DNA cistrons found in the short arms of the five human acrocentric chromosomes (13, 14, 15, 21 "dots" of variable size. (figs 1 and 2) . The lymphomas were all of B cell phenotype as shown by CD 20 staining and where there was an intervening "reactive" T lymphocytic infiltration these (CD3-positive) cells had only 1-0 to 1I5 AgNOR dots per nucleus and accounted for no more than 5% of the total cell count.
In the high grade lymphomas the PCNA positive cells ranged from 34-2 to 51-3%. These positive cells had mean AgNOR scores from 5-66 to 9-93, while the PCNA negative cells had a mean AgNOR score from 2-76 to (table) .
In the low grade lymphomas PCNA positive cells ranged from 18-0 to 28-4%. The positive cells had mean AgNOR scores from 5-4 to 8-39, while the PCNA negative cells had a mean AgNOR score from 1-49 to 4-63 (table) .
The PCNA score in tonsillar follicle centres ranged from 43-0 to 500% while in the interfollicular areas it was 2-0 to 7-5%. In follicle centre cells the AgNOR scores for the PCNA positive nuclei were from 1-9 to 6-89 and in interfollicular cells the range was from 1-67 to 6-79. The cells lacking PCNA activity in follicle centres had a mean AgNOR score of 2-09 to 3 05; in the interfollicular PCNA negative cells the AgNOR score was from 1-45 to 1-67 (table) .
Although the numbers of specimens were small, the quantity of data permitted statistical evaluation. At a 95% confidence interval, the difference between the AgNOR scores in PCNA positive and negative cells in high grade lymphomas was significant at p < 005. In low grade lymphomas, the difference between the AgNOR scores in PCNA positive and negative specimens was significant at p < 0-01. In interfollicular and follicle centre cells of the tonsil there was a significant difference in AgNOR counts between PCNA positive and negative cells at p<001 for both types of cells. 22 However, in these experiments the total amount of argyrophilia was calculated and not the number of AgNORs; as not all argyrophilia is due to transcriptionally active molecules the amount may not necessarily change in proportion to the cells' proliferative state. It seems that some of the AgNOR associated proteins to which the silver binds may have structural roles.
Discussion
In the current study we have further investigated the relation between AgNOR scores and cell proliferation using the PCNA antibody which unlike Ki67 reacts with paraffin wax sections. We found that the proliferating PCNA positive cells had higher AgNOR scores than the PCNA negative cells, and that both the numbers of PCNA positive cells and AgNORs were greater in high grade lymphomas than low grade lymphomas. However, the AgNOR counts were relatively high in PCNA negative cells (1 5-6-6) compared with counts in non-proliferating cells as shown by the interfollicular counts in the tonsil sections (1-5-1-7). The PCNA negative cell scores of the NHL specimens were also greater than the PCNA negative scores in the tonsil germinal centres (2 1-3-0). This may indicate that PCNA and AgNORs are presented at different stages of the cell cycle or may linger for different durations after mitosis. It is of interest that the cells lacking PCNA in both low and high grade lymphomas may still have relatively increased AgNOR scores compared to resting lymphoid cells. This may reflect a lack of differentiation rather than entry into cell cycle. 20 The small numbers of reactive T cells present in the specimens would appear to have low AgNOR scores. Thus although we have shown an association between PCNA labelling and AgNOR counts in NHL and therefore, yet again, an association between cell proliferation and AgNOR scores, it appears that PCNA negative cells still have relatively high counts in lymphomas. An identical phenomenon has recently been demonstrated in hyperproliferation of epithelial cells of the rat stomach.23This may result from the production of NORs lagging behind the PCNA epitope production; consequently this requires further investigation. It remains a mystery, however, to account for the apparently close relation which has been shown on several occasions between AgNOR and Ki67 counts for a variety of tumours. We still have much to pursue in relation to our understanding of the interrelations between the increasingly large numbers of proposed "markers" of cell proliferation.
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